L Trang
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Rheumatoid Arthritis Research and Therapies 6
- Systemic Lupus Erythematosus Research 2
-
- Inflammatory mediators and NSAID effects 3
- Co-authors
- G Borg (4 shared papers)Ulf Brodin (4 shared papers)B. Lund (2 shared papers)H. Pettersson (2 shared papers)Olle Lövgren (5 shared papers)C. Egsmose (1 shared paper)Einar Berg (1 shared paper)Elisabeth Granström (1 shared paper)
- Journals
- Scandinavian Journal of Rheumatology (6 papers)Inflammation Research (1 paper)Annals of the Rheumatic Diseases (1 paper)PubMed (3 papers)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)
In The Last Decade
L Trang
12 papers receiving 601 citations
Peers
Comparison fields: 5 of 80
- Rheumatology 428
- Hematology 145
- Pharmacology 114
- Pharmacology 45
- Genetics 54
Countries citing papers authored by L Trang
This map shows the geographic impact of L Trang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Trang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Trang more than expected).
Fields of papers citing papers by L Trang
This network shows the impact of papers produced by L Trang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Trang. The network helps show where L Trang may publish in the future.
Co-authors
The 21 scholars most cited alongside L Trang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. | 1995 | 262 |
| 2 | 1977 | 107 | |
| 3 | Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. | 1988 | 84 |
| 4 | 1983 | 51 | |
| 5 | Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. | 1991 | 43 |
| 6 | 1985 | 31 | |
| 7 | Diclophenax sodium (Voltaren) in rheumatoid arthritis: a double-blind comparison with indomethacin and placebo. | 1976 | 18 |
| 8 | 1989 | 11 | |
| 9 | 1979 | 11 | |
| 10 | 1980 | 6 | |
| 11 | 1983 | 5 | |
| 12 | 1980 | 2 |
About L Trang
L Trang is a scholar working on Rheumatology, Pharmacology, Cardiology and Cardiovascular Medicine, Immunology and Organic Chemistry, having authored 12 papers that have together received 631 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Inflammatory mediators and NSAID effects (3 papers), Systemic Lupus Erythematosus Research (2 papers), Hepatitis C virus research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Synthesis and Reactions of Organic Compounds (1 paper) and Macrophage Migration Inhibitory Factor (1 paper). The work is most often cited by research in Rheumatology (428 citations), Hematology (145 citations), Pharmacology (114 citations), Pharmacology (45 citations) and Genetics (54 citations). L Trang has collaborated with scholars based in Sweden, Norway and Canada. Frequent co-authors include G Borg, Ulf Brodin, B. Lund, H. Pettersson, Olle Lövgren, C. Egsmose, Einar Berg, Elisabeth Granström, Erik Allander and A.‐M. Udén. Their work appears in journals such as Scandinavian Journal of Rheumatology, Inflammation Research, Annals of the Rheumatic Diseases, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.